Showing results (61-70 of 194) with videos related to
Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2015
Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell TransplantationXiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, et al.Frontiers in Medicine|August 25, 2025
Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomesHai-Lu Sun, Xiang-Yu Zhao, Xiao-Dong Mo, et al.HLA|November 20, 2023
The impact of donor-specific anti-HLA antibody levels on primary poor graft function and graft rejection in rituximab desensitized haploidentical stem cell transplantationJing Liu, Xiang-Yu Zhao, Lan-Ping Xu, et al.Transplantation and Cellular Therapy|August 27, 2025
Long-term efficacy of EBV-specific T cells for EBV-PTLD after allogeneic stem cell transplantation: a real word studyHai-Lu Sun, Qiang Fu, Xiang- Yu Zhao, et al.Scientific Reports|May 23, 2024
COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantationQi Wen, Ze Guo, Xiao-Hui Zhang, et al.British Journal of Haematology|June 26, 2023
Outcomes of haploidentical haematopoietic stem cell transplantation for adolescent and young adults with acute myeloid leukaemiaWen-Xuan Huo, Qi Wen, Xiao-Hui Zhang, et al.Bone Marrow Transplantation|December 7, 2018
Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patientsWei Sun, Xiao-Dong Mo, Xiao-Hui Zhang, et al.International Journal of Cancer|August 21, 2014
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groupsXiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, et al.Annals of Hematology|January 8, 2021
Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblingsYan-Ru Ma, Lan-Ping Xu, Xiao-Hui Zhang, et al.Cell Transplantation|June 4, 2024
Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell TransplantationXin-Ya Jiang, Xiao-Hui Zhang, Lan-Ping Xu, et al.Pageof 20